CGEM

CULLINAN THERAPEUTICS INC

CGEM·230031106·US·Common Stock·Healthcare - Biotechnology-13D/G

CGEM (CULLINAN THERAPEUTICS INC) is held by 104 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($95.3M), STATE STREET CORP ($66.8M), VANGUARD CAPITAL MANAGEMENT LLC ($47.6M). Net institutional sentiment: Bullish.

104
Holders
(8 Elite)
$519.6M
Total Value
69% (108)
Consensus
74 buying - 34 selling
13F: Insider & Congress: Updated regularly
CGEM

Smart Money Verdict

View all
Loading verdict
Held by 104 funds
8 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 14, 2026 · Activists Aug 14, 2026 · Congress none

ActivistBLBVF PARTNERS L P/IL10.0%Aug 14, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.6.2%Aug 14, 2026
InsiderMJMichaelson JenniferExercise 30K shAug 13, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
5.2M(+17.6%)$95.3M0.0%+75.33%
35
Increased
3.7M(+44.2%)$66.8M0.0%+48.58%
40
Increased
2.6M(+5.3%)$47.6M0.0%+44.12%
31
Increased
2.4M(+38.6%)$43.1M0.4%+29.94%
46
Increased
1.5M(+13.1%)$28.2M0.0%+18.62%
32
Increased
1M(+15.5%)$19.1M0.0%+72.58%
33
Increased
1M(+119.9%)$18.2M0.0%+56.97%
46
Increased
738,741(+33.7%)$13.5M0.0%+39.71%
36
Increased
629,035(+6.7%)$11.5M0.0%+91.97%
30
Increased
581,338(+61.1%)$10.6M0.0%+81.68%
40
Increased
571,080(+27.1%)$10.4M0.0%+10.96%
34
Decreased
510,325(-1.2%)$9.3M0.0%+104.30%
0
Decreased
471,947(-41.4%)$8.6M0.0%+108.55%
0
Increased
464,034(+7.2%)$8.5M0.0%+19.28%
30
Increased
397,484(+57.3%)$7.2M0.0%+42.76%
39
Increased
382,840(+4.1%)$7M0.0%+111.30%
28
Increased
363,136(+5.9%)$6.6M0.0%+44.00%
29
Decreased
346,232(-0.1%)$6.3M0.0%+41.66%
0
Increased
326,811(+0.8%)$6M0.0%+142.47%
27
Increased
292,500(+1.2%)$5.3M0.0%+133.48%
27

Showing 1-20 of 111

1 / 6
CGEMCGEMCULLINAN THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used